FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
Dilip Davda recommend to "Avoid" the IPO.
Review By | Apply | May Apply | Neutral | Avoid | Not Rated |
---|---|---|---|---|---|
Count | 0 | 0 | 0 | 1 | 0 |
% | 0.00 | 0.00 | 0.00 | 100.00 | 0.00 |
Reviewer | Recommendation | Past Reviews |
---|---|---|
Dilip Davda | Avoid |
[Dilip Davda] The company has posted minuscule financial performances till FY21 and has marked bumper top and bottom line for the first half of the current fiscal. Since the company is having third party trading activity, sustainability of such performance going forward is a major concern. Even with this super current earning, its asking price is at a P/E of 54 making it a costly bet. There is no harm in ignoring this pricy offer. Read detail review...
achyut-healthcare-ipo Reviews, analysis and views by popular members. Read Achyut Healthcare Limited IPO reviews by retail investors to find recommended ipo to buy.
Post Recommendation Manage Your IPO Reviews
Review By | Apply | May Apply | Neutral | Avoid |
---|
Member | Review |
---|---|
No recommendation found. Be the first to post the
recommendation. |
Post Recommendation Manage Recommendations
Note:
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|